louisiana glp-1 side effect class action RA Lawsuit - Shreveport Lawyer Ozempic Lawsuit [July 2026 Update]

(1) Limitations of Use: Coadministration with other exenatide containing products is not recommended

To our knowledge, there is no similar case in the literature with this pattern of dissemination

Really important conversation, especially with how quickly GLP-1 use is growing

Each film-coated tablet of JANUVIA contains 32.13, 64.25, or 128.5 mg of sitagliptin phosphate monohydrate, which is equivalent to 25, 50, or 100 mg, respectively, of free base and the following inactive ingredients: microcrystalline cellulose, anhydrous dibasic calcium phosphate, croscarmellose sodium, magnesium stearate, sodium stearyl fumarate, and propyl gallate